Showing results (331-340 of 364) with videos related to
Sort By:
Pageof 37
Plos One|June 23, 2011
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C virusesMing-Lun Yeh, Chao-Hung Hung, Jee-Fu Huang, et al.Histopathology|July 30, 2013
HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs)Yu-Ching Wei, Fong-Fu Chou, Chien-Feng Li, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Taiwan consensus statement on the management of chronic hepatitis BRong-Nan Chien, Jia-Horng Kao, Cheng-Yuan Peng, et al.Gastroenterology Research and Practice|November 16, 2013
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in TaiwanWei-Chen Tai, Chien-Hua Chiu, Chih-Ming Liang, et al.Hepatology (Baltimore, Md.)|September 5, 2013
Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in TaiwanYen-Po Yeh, Tsung-Hui Hu, Po-Yuan Cho, et al.Journal of Infection and Public Health|June 4, 2023
A new collaborative care approach toward hepatitis C elimination in marginalized populationsWei-Wen Su, Chih-Chao Yang, Rene Wei-Jung Chang, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infectionKuo-Chin Chang, Po-Lin Tseng, Yi-Ying Wu, et al.Plos One|August 11, 2017
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis CChao-Min Huang, Kuo-Chin Chang, Chao-Hung Hung, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2017
Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal studyYi-Hao Yen, Ming-Chao Tsai, Cheng-Kun Wu, et al.Infection and Drug Resistance|October 2, 2019
A comparison between dexlansoprazole modified release-based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line <i>Helicobacter pylori</i> eradication: a prospective randomized trialWei-Chen Tai, Chih-Ming Liang, Kuo-Wei Bi, et al.Pageof 37